APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antipyretic Analgesics

Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

Selected research

Market Outlook & Growth Opportunities

Global Antipyretic Analgesics Market Outlook and Growth Opportunities 2026

31 December 2025197 pages

Choose your research edition.

Industry ResearchAntipyretic Analgesics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Antipyretic Analgesics Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Antipyretic Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antipyretic Analgesics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Antipyretic Analgesics Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.

Antipyretic analgesic of the world's main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.

Read the full market overview

This report provides an overview of the global Antipyretic Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antipyretic Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antipyretic Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antipyretic Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Antipyretic Analgesics Segment by Company

Mallinckrodt Pharmaceuticals

IOL

Anqiu Lu'an Pharmaceutical

Novacyl

BASF

Anhui BBCA Pharmaceuticals

Hubei Biocause

Xinhua Pharm

Granules India Limited

Huagang Pharm

Hebei Jiheng Pharmaceutical

Zhejiang Kangle Pharmaceutical

Hebei Jingye Medical Technology

MSPF

Antipyretic Analgesics Segment by Type

Paracetamol

Aspirin

Ibuprofen

Naproxen

Diclofenac

Oxaprozin

Dexibuprofen

Others

Antipyretic Analgesics Segment by Application

Adults

Children

Antipyretic Analgesics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antipyretic Analgesics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antipyretic Analgesics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antipyretic Analgesics significant trends, drivers, influence factors in global and regions.

6. To analyze Antipyretic Analgesics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antipyretic Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antipyretic Analgesics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antipyretic Analgesics industry.

Chapter 3: Detailed analysis of Antipyretic Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antipyretic Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antipyretic Analgesics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antipyretic Analgesics Industry Trends Table 2. Antipyretic Analgesics Industry Drivers Table 3. Antipyretic Analgesics Industry Opportunities and Challenges Table 4. Antipyretic Analgesics Industry Restraints Table 5. Global Antipyretic Analgesics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antipyretic Analgesics Revenue Share by Company (2021-2026) Table 7. Global Antipyretic Analgesics Sales Volume by Company (MT) & (2021-2026) Table 8. Global Antipyretic Analgesics Sales Volume Share by Company (2021-2026) Table 9. Global Antipyretic Analgesics Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Antipyretic Analgesics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antipyretic Analgesics Key Company Manufacturing Base & Headquarters Table 12. Global Antipyretic Analgesics Company, Product Type & Application Table 13. Global Antipyretic Analgesics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antipyretic Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Paracetamol Table 18. Significant Companies of Aspirin Table 19. Significant Companies of Ibuprofen Table 20. Significant Companies of Naproxen Table 21. Significant Companies of Diclofenac Table 22. Significant Companies of Oxaprozin Table 23. Significant Companies of Dexibuprofen Table 24. Significant Companies of Others Table 25. Global Antipyretic Analgesics Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 26. Global Antipyretic Analgesics Sales Volume by Type (2021-2026) & (MT) Table 27. Global Antipyretic Analgesics Sales Volume by Type (2027-2032) & (MT) Table 28. Global Antipyretic Analgesics Sales Volume Share by Type (2021-2026) Table 29. Global Antipyretic Analgesics Sales Volume Share by Type (2027-2032) Table 30. Global Antipyretic Analgesics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Antipyretic Analgesics Sales Value by Type (2021-2026) & (US$ Million) Table 32. Global Antipyretic Analgesics Sales Value by Type (2027-2032) & (US$ Million) Table 33. Global Antipyretic Analgesics Sales Value Share by Type (2021-2026) Table 34. Global Antipyretic Analgesics Sales Value Share by Type (2027-2032) Table 35. Significant Companies of Adults Table 36. Significant Companies of Children Table 37. Global Antipyretic Analgesics Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 38. Global Antipyretic Analgesics Sales Volume by Application (2021-2026) & (MT) Table 39. Global Antipyretic Analgesics Sales Volume by Application (2027-2032) & (MT) Table 40. Global Antipyretic Analgesics Sales Volume Share by Application (2021-2026) Table 41. Global Antipyretic Analgesics Sales Volume Share by Application (2027-2032) Table 42. Global Antipyretic Analgesics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Antipyretic Analgesics Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Antipyretic Analgesics Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Antipyretic Analgesics Sales Value Share by Application (2021-2026) Table 46. Global Antipyretic Analgesics Sales Value Share by Application (2027-2032) Table 47. Global Antipyretic Analgesics Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 48. Global Antipyretic Analgesics Sales by Region (2021-2026) & (MT) Table 49. Global Antipyretic Analgesics Sales Market Share by Region (2021-2026) Table 50. Global Antipyretic Analgesics Sales by Region (2027-2032) & (MT) Table 51. Global Antipyretic Analgesics Sales Market Share by Region (2027-2032) Table 52. Global Antipyretic Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Antipyretic Analgesics Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Antipyretic Analgesics Sales Value Share by Region (2021-2026) Table 55. Global Antipyretic Analgesics Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Antipyretic Analgesics Sales Value Share by Region (2027-2032) Table 57. Global Antipyretic Analgesics Market Average Price (USD/Kg) by Region (2021-2026) Table 58. Global Antipyretic Analgesics Market Average Price (USD/Kg) by Region (2027-2032) Table 59. Global Antipyretic Analgesics Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 60. Global Antipyretic Analgesics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Antipyretic Analgesics Sales by Country (2021-2026) & (MT) Table 62. Global Antipyretic Analgesics Sales Market Share by Country (2021-2026) Table 63. Global Antipyretic Analgesics Sales by Country (2027-2032) & (MT) Table 64. Global Antipyretic Analgesics Sales Market Share by Country (2027-2032) Table 65. Global Antipyretic Analgesics Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Antipyretic Analgesics Sales Value Market Share by Country (2021-2026) Table 67. Global Antipyretic Analgesics Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Antipyretic Analgesics Sales Value Market Share by Country (2027-2032) Table 69. Mallinckrodt Pharmaceuticals Company Information Table 70. Mallinckrodt Pharmaceuticals Business Overview Table 71. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 72. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio Table 73. Mallinckrodt Pharmaceuticals Recent Development Table 74. IOL Company Information Table 75. IOL Business Overview Table 76. IOL Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 77. IOL Antipyretic Analgesics Product Portfolio Table 78. IOL Recent Development Table 79. Anqiu Lu'an Pharmaceutical Company Information Table 80. Anqiu Lu'an Pharmaceutical Business Overview Table 81. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 82. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio Table 83. Anqiu Lu'an Pharmaceutical Recent Development Table 84. Novacyl Company Information Table 85. Novacyl Business Overview Table 86. Novacyl Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 87. Novacyl Antipyretic Analgesics Product Portfolio Table 88. Novacyl Recent Development Table 89. BASF Company Information Table 90. BASF Business Overview Table 91. BASF Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 92. BASF Antipyretic Analgesics Product Portfolio Table 93. BASF Recent Development Table 94. Anhui BBCA Pharmaceuticals Company Information Table 95. Anhui BBCA Pharmaceuticals Business Overview Table 96. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 97. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio Table 98. Anhui BBCA Pharmaceuticals Recent Development Table 99. Hubei Biocause Company Information Table 100. Hubei Biocause Business Overview Table 101. Hubei Biocause Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 102. Hubei Biocause Antipyretic Analgesics Product Portfolio Table 103. Hubei Biocause Recent Development Table 104. Xinhua Pharm Company Information Table 105. Xinhua Pharm Business Overview Table 106. Xinhua Pharm Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 107. Xinhua Pharm Antipyretic Analgesics Product Portfolio Table 108. Xinhua Pharm Recent Development Table 109. Granules India Limited Company Information Table 110. Granules India Limited Business Overview Table 111. Granules India Limited Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 112. Granules India Limited Antipyretic Analgesics Product Portfolio Table 113. Granules India Limited Recent Development Table 114. Huagang Pharm Company Information Table 115. Huagang Pharm Business Overview Table 116. Huagang Pharm Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 117. Huagang Pharm Antipyretic Analgesics Product Portfolio Table 118. Huagang Pharm Recent Development Table 119. Hebei Jiheng Pharmaceutical Company Information Table 120. Hebei Jiheng Pharmaceutical Business Overview Table 121. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 122. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio Table 123. Hebei Jiheng Pharmaceutical Recent Development Table 124. Zhejiang Kangle Pharmaceutical Company Information Table 125. Zhejiang Kangle Pharmaceutical Business Overview Table 126. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 127. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio Table 128. Zhejiang Kangle Pharmaceutical Recent Development Table 129. Hebei Jingye Medical Technology Company Information Table 130. Hebei Jingye Medical Technology Business Overview Table 131. Hebei Jingye Medical Technology Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 132. Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio Table 133. Hebei Jingye Medical Technology Recent Development Table 134. MSPF Company Information Table 135. MSPF Business Overview Table 136. MSPF Antipyretic Analgesics Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 137. MSPF Antipyretic Analgesics Product Portfolio Table 138. MSPF Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Antipyretic Analgesics Distributors List Table 142. Antipyretic Analgesics Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Antipyretic Analgesics Product Image Figure 2. Global Antipyretic Analgesics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antipyretic Analgesics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antipyretic Analgesics Sales (2021-2032) & (MT) Figure 5. Global Antipyretic Analgesics Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Antipyretic Analgesics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Paracetamol Image Figure 10. Aspirin Image Figure 11. Ibuprofen Image Figure 12. Naproxen Image Figure 13. Diclofenac Image Figure 14. Oxaprozin Image Figure 15. Dexibuprofen Image Figure 16. Others Image Figure 17. Global Antipyretic Analgesics Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 18. Global Antipyretic Analgesics Sales Volume Share 2021 VS 2025 VS 2032 Figure 19. Global Antipyretic Analgesics Sales Volume Share by Type (2021-2032) Figure 20. Global Antipyretic Analgesics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Antipyretic Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Antipyretic Analgesics Sales Value Share by Type (2021-2032) Figure 23. Adults Image Figure 24. Children Image Figure 25. Global Antipyretic Analgesics Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 26. Global Antipyretic Analgesics Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Antipyretic Analgesics Sales Volume Share by Application (2021-2032) Figure 28. Global Antipyretic Analgesics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Antipyretic Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Antipyretic Analgesics Sales Value Share by Application (2021-2032) Figure 31. Global Antipyretic Analgesics Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 32. Global Antipyretic Analgesics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Antipyretic Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Antipyretic Analgesics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Antipyretic Analgesics Sales Value (2021-2032) & (US$ Million) Figure 36. North America Antipyretic Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Antipyretic Analgesics Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Antipyretic Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Antipyretic Analgesics Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Antipyretic Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Antipyretic Analgesics Sales Value (2021-2032) & (US$ Million) Figure 42. South America Antipyretic Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Antipyretic Analgesics Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Antipyretic Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Antipyretic Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Antipyretic Analgesics Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Antipyretic Analgesics Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Paracetamol
  • Aspirin
  • Ibuprofen
  • Naproxen
  • Diclofenac
  • Oxaprozin
  • Dexibuprofen
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Mallinckrodt Pharmaceuticals
  • IOL
  • Anqiu Lu'an Pharmaceutical
  • Novacyl
  • BASF
  • Anhui BBCA Pharmaceuticals
  • Hubei Biocause
  • Xinhua Pharm
  • Granules India Limited
  • Huagang Pharm
  • Hebei Jiheng Pharmaceutical
  • Zhejiang Kangle Pharmaceutical
  • Hebei Jingye Medical Technology
  • MSPF

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antipyretic Analgesics Sales Value (2021-2032)
  4. 1.2.2 Global Antipyretic Analgesics Sales Volume (2021-2032)
  5. 1.2.3 Global Antipyretic Analgesics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antipyretic Analgesics Market Dynamics
  1. 2.1 Antipyretic Analgesics Industry Trends
  2. 2.2 Antipyretic Analgesics Industry Drivers
  3. 2.3 Antipyretic Analgesics Industry Opportunities and Challenges
  4. 2.4 Antipyretic Analgesics Industry Restraints
3 Antipyretic Analgesics Market by Company
  1. 3.1 Global Antipyretic Analgesics Company Revenue Ranking in 2025
  2. 3.2 Global Antipyretic Analgesics Revenue by Company (2021-2026)
  3. 3.3 Global Antipyretic Analgesics Sales Volume by Company (2021-2026)
  4. 3.4 Global Antipyretic Analgesics Average Price by Company (2021-2026)
  5. 3.5 Global Antipyretic Analgesics Company Ranking (2024-2026)
  6. 3.6 Global Antipyretic Analgesics Company Manufacturing Base and Headquarters
  7. 3.7 Global Antipyretic Analgesics Company Product Type and Application
  8. 3.8 Global Antipyretic Analgesics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antipyretic Analgesics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antipyretic Analgesics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antipyretic Analgesics Market by Type
  1. 4.1 Antipyretic Analgesics Type Introduction
  2. 4.1.1 Paracetamol
  3. 4.1.2 Aspirin
  4. 4.1.3 Ibuprofen
  5. 4.1.4 Naproxen
  6. 4.1.5 Diclofenac
  7. 4.1.6 Oxaprozin
  8. 4.1.7 Dexibuprofen
  9. 4.1.8 Others
  10. 4.2 Global Antipyretic Analgesics Sales Volume by Type
  11. 4.2.1 Global Antipyretic Analgesics Sales Volume by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Antipyretic Analgesics Sales Volume by Type (2021-2032)
  13. 4.2.3 Global Antipyretic Analgesics Sales Volume Share by Type (2021-2032)
  14. 4.3 Global Antipyretic Analgesics Sales Value by Type
  15. 4.3.1 Global Antipyretic Analgesics Sales Value by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Antipyretic Analgesics Sales Value by Type (2021-2032)
  17. 4.3.3 Global Antipyretic Analgesics Sales Value Share by Type (2021-2032)
5 Antipyretic Analgesics Market by Application
  1. 5.1 Antipyretic Analgesics Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Antipyretic Analgesics Sales Volume by Application
  5. 5.2.1 Global Antipyretic Analgesics Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antipyretic Analgesics Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Antipyretic Analgesics Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Antipyretic Analgesics Sales Value by Application
  9. 5.3.1 Global Antipyretic Analgesics Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antipyretic Analgesics Sales Value by Application (2021-2032)
  11. 5.3.3 Global Antipyretic Analgesics Sales Value Share by Application (2021-2032)
6 Antipyretic Analgesics Regional Sales and Value Analysis
  1. 6.1 Global Antipyretic Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antipyretic Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Antipyretic Analgesics Sales by Region: 2021-2026
  4. 6.2.2 Global Antipyretic Analgesics Sales by Region (2027-2032)
  5. 6.3 Global Antipyretic Analgesics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antipyretic Analgesics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antipyretic Analgesics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antipyretic Analgesics Sales Value by Region (2027-2032)
  9. 6.5 Global Antipyretic Analgesics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antipyretic Analgesics Sales Value (2021-2032)
  12. 6.6.2 North America Antipyretic Analgesics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antipyretic Analgesics Sales Value (2021-2032)
  15. 6.7.2 Europe Antipyretic Analgesics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antipyretic Analgesics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antipyretic Analgesics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antipyretic Analgesics Sales Value (2021-2032)
  21. 6.9.2 South America Antipyretic Analgesics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antipyretic Analgesics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antipyretic Analgesics Sales Value Share by Country, 2025 VS 2032
7 Antipyretic Analgesics Country-level Sales and Value Analysis
  1. 7.1 Global Antipyretic Analgesics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antipyretic Analgesics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antipyretic Analgesics Sales by Country (2021-2032)
  4. 7.3.1 Global Antipyretic Analgesics Sales by Country (2021-2026)
  5. 7.3.2 Global Antipyretic Analgesics Sales by Country (2027-2032)
  6. 7.4 Global Antipyretic Analgesics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antipyretic Analgesics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antipyretic Analgesics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antipyretic Analgesics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antipyretic Analgesics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antipyretic Analgesics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mallinckrodt Pharmaceuticals
  2. 8.1.1 Mallinckrodt Pharmaceuticals Company Information
  3. 8.1.2 Mallinckrodt Pharmaceuticals Business Overview
  4. 8.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio
  6. 8.1.5 Mallinckrodt Pharmaceuticals Recent Developments
  7. 8.2 IOL
  8. 8.2.1 IOL Company Information
  9. 8.2.2 IOL Business Overview
  10. 8.2.3 IOL Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 IOL Antipyretic Analgesics Product Portfolio
  12. 8.2.5 IOL Recent Developments
  13. 8.3 Anqiu Lu'an Pharmaceutical
  14. 8.3.1 Anqiu Lu'an Pharmaceutical Company Information
  15. 8.3.2 Anqiu Lu'an Pharmaceutical Business Overview
  16. 8.3.3 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio
  18. 8.3.5 Anqiu Lu'an Pharmaceutical Recent Developments
  19. 8.4 Novacyl
  20. 8.4.1 Novacyl Company Information
  21. 8.4.2 Novacyl Business Overview
  22. 8.4.3 Novacyl Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novacyl Antipyretic Analgesics Product Portfolio
  24. 8.4.5 Novacyl Recent Developments
  25. 8.5 BASF
  26. 8.5.1 BASF Company Information
  27. 8.5.2 BASF Business Overview
  28. 8.5.3 BASF Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BASF Antipyretic Analgesics Product Portfolio
  30. 8.5.5 BASF Recent Developments
  31. 8.6 Anhui BBCA Pharmaceuticals
  32. 8.6.1 Anhui BBCA Pharmaceuticals Company Information
  33. 8.6.2 Anhui BBCA Pharmaceuticals Business Overview
  34. 8.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio
  36. 8.6.5 Anhui BBCA Pharmaceuticals Recent Developments
  37. 8.7 Hubei Biocause
  38. 8.7.1 Hubei Biocause Company Information
  39. 8.7.2 Hubei Biocause Business Overview
  40. 8.7.3 Hubei Biocause Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hubei Biocause Antipyretic Analgesics Product Portfolio
  42. 8.7.5 Hubei Biocause Recent Developments
  43. 8.8 Xinhua Pharm
  44. 8.8.1 Xinhua Pharm Company Information
  45. 8.8.2 Xinhua Pharm Business Overview
  46. 8.8.3 Xinhua Pharm Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Xinhua Pharm Antipyretic Analgesics Product Portfolio
  48. 8.8.5 Xinhua Pharm Recent Developments
  49. 8.9 Granules India Limited
  50. 8.9.1 Granules India Limited Company Information
  51. 8.9.2 Granules India Limited Business Overview
  52. 8.9.3 Granules India Limited Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Granules India Limited Antipyretic Analgesics Product Portfolio
  54. 8.9.5 Granules India Limited Recent Developments
  55. 8.10 Huagang Pharm
  56. 8.10.1 Huagang Pharm Company Information
  57. 8.10.2 Huagang Pharm Business Overview
  58. 8.10.3 Huagang Pharm Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Huagang Pharm Antipyretic Analgesics Product Portfolio
  60. 8.10.5 Huagang Pharm Recent Developments
  61. 8.11 Hebei Jiheng Pharmaceutical
  62. 8.11.1 Hebei Jiheng Pharmaceutical Company Information
  63. 8.11.2 Hebei Jiheng Pharmaceutical Business Overview
  64. 8.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio
  66. 8.11.5 Hebei Jiheng Pharmaceutical Recent Developments
  67. 8.12 Zhejiang Kangle Pharmaceutical
  68. 8.12.1 Zhejiang Kangle Pharmaceutical Company Information
  69. 8.12.2 Zhejiang Kangle Pharmaceutical Business Overview
  70. 8.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio
  72. 8.12.5 Zhejiang Kangle Pharmaceutical Recent Developments
  73. 8.13 Hebei Jingye Medical Technology
  74. 8.13.1 Hebei Jingye Medical Technology Company Information
  75. 8.13.2 Hebei Jingye Medical Technology Business Overview
  76. 8.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio
  78. 8.13.5 Hebei Jingye Medical Technology Recent Developments
  79. 8.14 MSPF
  80. 8.14.1 MSPF Company Information
  81. 8.14.2 MSPF Business Overview
  82. 8.14.3 MSPF Antipyretic Analgesics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 MSPF Antipyretic Analgesics Product Portfolio
  84. 8.14.5 MSPF Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antipyretic Analgesics Value Chain Analysis
  2. 9.1.1 Antipyretic Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antipyretic Analgesics Sales Mode & Process
  6. 9.2 Antipyretic Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antipyretic Analgesics Distributors
  9. 9.2.3 Antipyretic Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst